Principles of policy Framework in the Pharmaceutical wholesale and retail system in lower income European Countries von Inotai, A, Csanadi, M, Hanko, B, Kalo, Z

Volltext

Transferability Of International Evidence On The Benefits Of Innovative Medicines Into Central Eastern European Countries von Inotai, A, Kalo, Z, Petrova, G, Vitezic, D

Volltext

Occurrence, Survival And Annual Cost of Colorectal-, Breast-, Prostate- and Lung Cancer in Hungary von Inotai, A, Abonyi-Tóth, Z, Rokszin, G, Voko, Z

Volltext

Relationship Between Medication Adherence and Quality of Life in COPD – Systematic Review von Ágh, T, Inotai, A, Bártfai, Z, Mészáros, Á

Volltext

PIH33 Utility and Human Capital Loss in Asthma, Chronic Obstructive Pulmonary Disease and Rheumatoid Arthritis – The Impact of Prevalence, Disease Specific Mortality and Utility De... von Meszaros, A, Agh, T, Inotai, A

Volltext

PHP44 International Comparison of Pharmaceutical Expenditure in Middle Income Countries: Methodological Questions von Kalo, Z, Inotai, A, Merész, G

Volltext

Impact of Switching on Health Care Costs and Outcomes in Generic Drug Policies von Kalo, Z, Abonyi-Tóth, Z, Rokszin, G, Katona, L, Ágh, T, Inotai, A

Volltext

PHP83 The Economic Burden of Disease Related Malnutrition in Europe von Kalo, Z, Inotai, A, Nuijten, M

Volltext

PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary Disease von Agh, T, Inotai, A, Meszaros, A

Volltext

PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary: Rational Decisions in Challenging Economic times? von Inotai, A, Merész, G, Kalo, Z

Volltext

Assessment of Generic Drug Policy Implementation by Measuring Persistence with Antihypertensive Drug Therapies After Patent Expiry von Abonyi-Tóth, Z, Kalo, Z, Ágh, T, Inotai, A, Katona, L, Rokszin, G, Jozwiak-Hagymásy, J

Volltext

RWD154 Clinical Characteristics and Pathways of Care of Breast Cancer Patients Receiving Targeted Therapy in Hungary von Erdősi, D, Csanády, B, Zemplényi, A, Inotai, A, Agh, T

Volltext

PNS290 EVIDENCE-BASED VALUE FRAMEWORK FOR THE EVALUATION OF CLINICAL PHARMACY SERVICES von Gyimesi, N., Kalo, Z., Inotai, A.

Volltext

PDG10 IMPROVING THE BUSINESS MODEL OF VALUE ADDED MEDICINES: NEW VALUE ASSESSMENT FRAMEWORK IS NEEDED von Petykó, Z., Inotai, A., Kaló, Z.

Volltext

PCR127 Eliciting Patient Experience for Value Assessment in a Case Study of Spinal Muscular Atrophy von Hosszú, D., McQueen, R., Nair, K., Mendola, N., Parsons, J., Zemplényi, A., Inotai, A.

Volltext

POSB376 Limited Published Quantitative Evidence on Medication Adherence of Multimorbid Elderly Women with Polypharmacotherapy: Results of a Systematic Literature Review von Erdősi, D, Agh, T, Vajda, P, Zemplényi, A, Kovács, S, Inotai, A

Volltext

HPR95 Opportunities and Challenges for Value Added Medicines: Results of a Scoping Research Based on Expert Interviews von Petykó, Z, Inotai, A, Espin, J, O’Keeffe, DT, O'Mahony, JF, Czech, M, Kalo, Z

Volltext

PCN361 - HEALTH ECONOMIC VALUE PROPOSITIONS FOR SUBCUTANEOUS TRASTUZUMAB AND THEIR TRANSFERABILITY TO CENTRAL-EASTERN EUROPEAN COUNTRIES von Inotai, A., Ágh, T., Karpenko, A.W., Zemplényi, A., Kaló, Z.

Volltext

PDB106 - ASSESSING THE HEALTH AND ECONOMIC IMPACT OF PHARMACEUTICAL CARE IN ELDERLY PATIENTS WITH DIABETES: A SYSTEMATIC LITERATURE REVIEW von Obeng, G.D., Inotai, A., Hankó, B., Ágh, T., Csanádi, M.

Volltext

PCN39 Impact of Medication Non-Adherence on Hard Clinical Endpoints in Patients with Breast Cancer: Results of a Systematic Literature Review von Inotai, A., Senkus, E., Maris, R.T., Kovács, S., Kaló, Z., Tamas, A.

Volltext